Biotech News
Pulse Biosciences to Present at the BofA Securities 2026 Healthcare Conference
investors.pulsebiosciences.com2026-05-08 11:07 EST
HAYWARD, Calif. --(BUSINESS WIRE)--May 8, 2026-- Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse™ technology using proprietary nanosecond pulsed field ablation (nsPFA™) energy, today announced plans to participate in the upcoming BofA Securities 2026 Healthcare Conference in Las Vegas,